Alexis Vedder

418 total citations
7 papers, 70 citations indexed

About

Alexis Vedder is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Alexis Vedder has authored 7 papers receiving a total of 70 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Alexis Vedder's work include Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and interferon and immune responses (1 paper). Alexis Vedder is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and interferon and immune responses (1 paper). Alexis Vedder collaborates with scholars based in United States and Taiwan. Alexis Vedder's co-authors include Eric Padron, Amy F. McLemore, Christina R. Hartigan, Maria E. Balasis, Marie McConkey, Hsin‐An Hou, Monica Schenone, Omar Abdel‐Wahab, Nicole D. Vincelette and Grace Ward and has published in prestigious journals such as Blood, Leukemia and JCI Insight.

In The Last Decade

Alexis Vedder

7 papers receiving 69 citations

Peers

Alexis Vedder

MB

IMMUN

HEMAT

GENET

ONCOL

Christopher T. Letson United States

Sarah K. Wideman United Kingdom

Marioara F. Ciuculescu United States

Anitria Cotton United States

Amy F. McLemore United States

Tiina Kasanen Finland

Inge Vrelust Belgium

Gino M Dettorre United States

Francesca Guijarro Spain

Mor Ngom Canada

Christopher T. Letson United States

Alexis Vedder

34 ×0.8

MB

8 ×0.4

IMMUN

35 ×1.7

HEMAT

25 ×1.5

GENET

11 ×0.9

ONCOL

Citations per year, relative to Alexis Vedder Alexis Vedder (= 1×) peers Christopher T. Letson

Countries citing papers authored by Alexis Vedder

Since Specialization

Citations

This map shows the geographic impact of Alexis Vedder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexis Vedder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexis Vedder more than expected).

Fields of papers citing papers by Alexis Vedder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexis Vedder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexis Vedder. The network helps show where Alexis Vedder may publish in the future.

Co-authorship network of co-authors of Alexis Vedder

This figure shows the co-authorship network connecting the top 25 collaborators of Alexis Vedder. A scholar is included among the top collaborators of Alexis Vedder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexis Vedder. Alexis Vedder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

McLemore, Amy F., Hsin‐An Hou, Grace Ward, et al.. (2022). Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromes. JCI Insight. 7(15). 26 indexed citations

2.

Balasis, Maria E., Traci Kruer, Lei Sun, et al.. (2022). The Long Non-Coding RNA MALAT1 Is Necessary for Hematopoietic Stem and Progenitor Cell Expansion and Preleukemic Myeloproliferation in TET2 Deficient Myeloid Neoplasms. Blood. 140(Supplement 1). 1991–1993. 1 indexed citations

3.

Belizaire, Roger, Sebastian Koochaki, Namrata D. Udeshi, et al.. (2021). CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1. Blood. 137(16). 2209–2220. 29 indexed citations

4.

Belizaire, Roger, Sebastian Koochaki, Namrata D. Udeshi, et al.. (2019). Oncogenic Mechanisms of CBL E3 Ubiquitin Ligase Mutations in Myeloid Malignancies. Blood. 134(Supplement_1). 563–563. 1 indexed citations

5.

Hunter, Anthony M., Christopher T. Letson, Amy E. DeZern, et al.. (2019). Patient Derived Xenografts (PDX) Recapitulate Ruxolitinib Clinical Trial Responses and Identify a Novel Combination Therapy for Chronic Myelomonocytic Leukemia (CMML). Blood. 134(Supplement_1). 2984–2984. 1 indexed citations

6.

Vedder, Alexis, Natalie Ragland, Maria E. Balasis, et al.. (2019). Effects of Corynebacterium bovis on Engraftment of Patient-derived Chronic-Myelomonocytic Leukemia Cells in NSGS Mice. Comparative Medicine. 69(4). 276–282. 11 indexed citations

7.

Ball, Markus, Yonggang Zhao, Maria E. Balasis, et al.. (2017). Intrapatient functional clonality deconvoluted by coupling intracellular flow cytometry and next-generation sequencing in human leukemia. Leukemia. 32(2). 532–538. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact